Tag Archives: Dengue Vaccine

Research looks into the impact and cost-effectiveness of the Dengvaxia vaccine under a host of varying conditions

Exeter, UK, 01-Dec-2016 — /EuropaWire/ — The first licensed vaccine for the potentially life-threatening dengue virus should only be used in moderate-to high impacted regions, new research has predicted. A team of international researchers, including Dr Mario Recker from the University … Read the full press release

Dengue vaccine: Sanofi Pasteur’s Dengvaxia® receives regulatory approval in Brazil

Global introduction of the first Dengue Vaccine gains further momentum with this third approval in a row in an endemic country – With 1.4 million dengue cases reported this year, Brazil stands to gain tremendous value from this new dengue … Read the full press release

New England Journal of Medicine analyses: Sanofi Pasteur’s Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue

– The highest burden of dengue disease globally in endemic countries is in pre-adolescent to adults age group[1],[2],[3] – In a new pooled analysis, dengue vaccine candidate protected two out of three volunteers aged 9 years and older against all four … Read the full press release